https://www.tensorflow.org/probability/api_docs/python/tfp/substrates/jax/distributions/normal_conjugates_known_scale_predictive
Posterior predictive Normal distribution w. conjugate prior on the mean.
tfpsubstratesjaxdistributionsnormal
https://www.agcbio.com/proveo-partnership-antibody-drug-conjugates
AGC Biologics along with 2 other world class partners, provides complete antibody drug conjugate development, manufacturing, and fill & finish.
antibodydrugconjugatesadcmanufacturing
https://www.prnewswire.com/news-releases/antibody-drug-conjugates-adc-market-worth-19-8-billion--marketsandmarkets-301948054.html
/PRNewswire/ -- The Antibody Drug Conjugates (ADC) industry represents a cutting-edge and rapidly evolving sector within the field of biopharmaceuticals....
antibodydrugconjugatesadcmarket
https://www.news-medical.net/industry-focus/Event-guide-5th-Novel-Conjugates-Summit-2026
The conjugate space is evolving fast — beyond classic ADCs into degrader-conjugates, oligonucleotide conjugates, bispecific ADCs and more.
eventguidenovelconjugatessummit
https://www.imarcgroup.com/antibody-drug-conjugates-market/toc
The global antibody drug conjugates market size reached USD 9.4 Billion in 2024 and expected to reach USD 50.2 Billion by 2033 with a CAGR of 19.45%.
market sizetocantibodydrugconjugates
https://www.frontiersin.org/journals/chemistry/articles/10.3389/fchem.2020.00284/full
Vaccines are powerful tools that can activate the immune system for protection against various diseases. As carbohydrates can play important roles in immune ...
frontierscarbohydrateconjugatesvaccinedevelopments
https://www.alliedmarketresearch.com/antibody-drug-caonjugate-market
Antibody drug conjugates market to reach $3,198 mn by 2023, at 12.9% CAGR, market boost by demand for cost-effective and quality cancer treatment
market sizegrowth industryantibodydrugconjugates
https://www.allucent.com/resources/article/harnessing-antibody-drug-conjugates-adcs-in-oncology-pathways-to-clinical-success
Oct 31, 2025 - Read the full article on harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success
harnessingantibodydrugconjugatesadcs